Pacific Biosciences Completes $109M Series F Financing Round
Summary
, a Menlo Park, California-based company developing a technology platform for real-time detection of biological events at single molecule resolution, has completed a $109m Series Fround.The round also includes a previously announced $50m strategic investment by Gen-Probe Incorporated As stated by Hugh Martin, Chairman and CEO of Pacific Biosciences, the funds will be used to support operations as the company begins ramping production capabilities for the commercial launch of the company’s first product, PacBio RS system, a third generation sequencing system based on its Single Molecule Real Time (SMRT™) platform.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected